The "Wolverine Stack": What the Name Refers To and What the Evidence Supports

"Wolverine stack" and "Wolverine peptides" are internet nicknames, borrowed from a comic-book character with an exaggerated capacity for tissue repair. In practice the phrase almost always refers to the combination of BPC-157 and TB-500. The name is marketing rather than science, and it makes claims that neither compound's published literature supports. This article explains what the two molecules actually are and how strong the evidence is.

BPC-157

BPC-157 is a synthetic 15-amino-acid peptide, derived from a sequence found in a protein in gastric juice, hence "Body Protection Compound". Almost all of the published work comes from a small number of research groups, and it is overwhelmingly preclinical: rodent models of tendon, ligament, muscle and gastrointestinal injury, and studies of angiogenic and growth factor signalling. Human data is minimal. See the BPC-157 research overview.

TB-500

TB-500 is marketed as a synthetic fragment of thymosin beta-4, a 43-amino-acid protein involved in actin regulation, cell migration and tissue repair models. Suppliers differ on the exact sequence sold as TB-500, which is one more reason to check the identity data on a COA. See TB-500 and thymosin beta-4 research.

Why the Two Are Discussed Together

The rationale in online discussion is that the two act on different pathways, one associated with growth-factor and angiogenic signalling, the other with actin dynamics and cell migration, so combining them might be complementary. That is a hypothesis. No controlled human study of the combination has been published, and the preclinical literature on each compound alone is limited. Our comparison of the two is in BPC-157 vs TB-500: what the evidence shows.

What the Name Gets Wrong

• •It implies an outcome. No published evidence supports a "super-healing" claim for either compound.
• •It implies a protocol. Combination protocols circulating online are not derived from clinical studies.
• •It implies safety. Absence of human trials means absence of human safety data, not evidence of safety.

Regulatory Position in Australia

BPC-157 was added to Schedule 4 (prescription-only) of the Poisons Standard in June 2024, and "research use only" labelling is not an exemption from scheduling. Scheduling attaches to the substance and changes over time, so verify the current status of both compounds. See are research peptides legal in Australia. Both compounds are also listed as prohibited in sport under WADA's rules for non-approved substances, so athletes should check the current list.

Quality Matters More Than the Nickname

Because the combination is popular, it is a common target for under-dosed and mislabelled products. Documentation to look for: a batch-specific COA, an independent laboratory, and identity confirmed by mass spectrometry. See how to spot a scam peptide supplier. We supply a single-vial BPC-157 + TB-500 blend for laboratory work, and each compound is also listed individually: BPC-157 and TB-500.

Frequently Asked Questions

What is the Wolverine stack?

A nickname for the combination of BPC-157 and TB-500.

Is there evidence it works?

There are no controlled human studies of the combination, and the evidence for each compound alone is mostly preclinical.

Is it legal in Australia?

BPC-157 is a Schedule 4 substance, and neither compound is approved as a medicine. See the legality guide above.

Disclaimer: All compounds referenced are supplied for in-vitro laboratory research only and are not for human or veterinary use. This article is educational and is not medical advice. It describes an internet nickname and makes no claim about the effects of any compound.